moxisylyte has been researched along with Abnormalities, Multiple in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Abnormalities, Multiple: Congenital abnormalities that affect more than one organ or body structure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ritch, R | 1 |
| Wand, M | 1 |
1 other study available for moxisylyte and Abnormalities, Multiple
| Article | Year |
|---|---|
Treatment of the Weill-Marchesani syndrome.
Topics: Abnormalities, Multiple; Ectopia Lentis; Glaucoma; Humans; Lens Subluxation; Lens, Crystalline; Moxi | 1981 |